NCT06815224Not yet recruiting
The Role of Perirenal Fat As Predictor in Diabetic Nephropathy
Source: ClinicalTrials.gov · Last updated 7 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
1 detect the relationship between perirenal fat thickness (PrFT) and estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes (T2DM). 2)Explored the relationship between PRF thickness and the onset and progression of albuminuria in patients with diabetes 3)Evaluate associations between obesity-related markers with albuminuria and advanced kidney disease in patients with type 2 diabetes mellitus (DM)
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 26 May 2024
- Start date
- 1 Mar 2025
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- Assiut University
- Diseases
- Chronic kidney disease
- NCT number
- NCT06815224
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Mar 2025 to the primary completion date, 1 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- b. Exclusion criteria:
- patients with a history of malignancy and surgical trauma.
- patients diagnosed with nondiabetic renal diseases
- Patients with renal replacement therapy (renal transplant or dialysis patients), renal morphological abnormalities (difference in kidney length between the two cm, solitary kidney or multiple kidneys, congenital kidney abnormalities, polycystic kidney, and hydronephrosis), liver cirrhosis.
- Insulin dependent diabetes
- Thyroid disease
Who the study is looking for
- \- Patients with T2DM aged 18-70 were included in this study. T2DM was diagnosed according to American Diabetes Association (ADA) ,Data collection will obtained over one year from October 2024 to October 2025.
- Clinical diagnosis of Alzheimer's Disease Must be able to swallow tablets
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.